Molecular Partners AG (MOLN) stock
MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.67−0.19 (-6.82%)
Close on Nov 18, 2026Market cap $107.60MP/E –Yield –
Molecular Partners free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -CHF 51.97M. The highest annual figure on record is CHF 117.39M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CHF 51.97M | – |
| FY2024 | Dec 31, 2024 | -CHF 59.95M | – |
| FY2023 | Dec 31, 2023 | -CHF 59.58M | -150.8% |
| FY2022 | Dec 31, 2022 | CHF 117.39M | – |
| FY2021 | Dec 31, 2021 | -CHF 91.89M | – |
| FY2020 | Dec 31, 2020 | -CHF 30.43M | – |
| FY2019 | Dec 31, 2019 | -CHF 2.22M | – |
See a number that looks wrong?